Zymeworks Inc. Common Stock (ZYME) — Cash Flow Quality Index
Zymeworks Inc. Common Stock (ZYME) has a Cash Flow Quality Index of 5.21x as of June 2025. Operating cash flow of $12.07 Million exceeds net income of $2.32 Million, indicating high earnings quality where cash backs reported profits. Explore how efficiently does Zymeworks Inc. Common Stock generate cash to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Zymeworks Inc. Common Stock Cash Flow Quality Index (2022–2022)
Historical Cash Flow Quality Index for Zymeworks Inc. Common Stock across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Zymeworks Inc. Common Stock (ZYME) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Zymeworks Inc. Common Stock (2022–2022)
Year-by-year earnings quality comparison for Zymeworks Inc. Common Stock. For live market cap and the full company financial profile, see Zymeworks Inc. Common Stock market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 1.16x | $144.11 Million | $124.34 Million | — |